The most common HER3 alteration in bladder cancer is mutation, with 10% of all bladder cancers across 16 non-redundant studies in cBioPortal harboring a HER3 mutation (n = 2419) (Figure 2) [27,28]. This evidence concerns the gene ERBB3 and urinary bladder carcinoma.